Diabetic neuropathy - Symptoms, Causes, Treatment & Prevention

```html

Overview

Diabetic neuropathy (DN) is a type of nerve damage that occurs as a long‑term complication of diabetes mellitus. It most often affects the peripheral nerves of the hands and feet, but can involve autonomic nerves that control internal organs. DN develops gradually, typically after years of uncontrolled high blood glucose, and it is one of the leading causes of morbidity in people with diabetes.

Who it affects

• Adults with type 1 or type 2 diabetes – prevalence rises with disease duration.
• ≈ 30–50 % of people with diabetes will develop some form of neuropathy during their lifetime (American Diabetes Association, 2024).
• Risk increases after 10 years of diabetes; > 70 % of patients with > 20 years’ disease have neuropathy.

Although men and women are affected at similar rates, certain ethnic groups (e.g., African‑American, Hispanic, and Native American populations) experience higher rates of diabetes complications, including neuropathy, often due to disparities in access to care and glycemic control.

Symptoms

Symptoms vary according to the type of nerve involved. Below is a comprehensive list:

Peripheral (sensorimotor) neuropathy

• Numbness or reduced sensation – typically begins in the toes and progresses upward.
• Tingling or “pins‑and‑needles” – a prickling sensation often described as “crawling.”
• Burning pain – may be constant or intermittent, often worse at night.
• Sharp, shooting pains – especially after walking (sometimes called “diabetic foot pain”).
• Loss of proprioception – difficulty sensing foot position, leading to clumsiness.
• Muscle weakness – may cause foot drop or difficulty gripping objects.

Autonomic neuropathy

• Gastrointestinal – nausea, vomiting, constipation, diarrhea, or gastroparesis (delayed stomach emptying).
• Cardiovascular – orthostatic hypotension (drop in blood pressure upon standing), resting tachycardia, or silent myocardial ischemia.
• Genitourinary – bladder dysfunction, urinary retention, erectile dysfunction.
• Sudomotor – abnormal sweating patterns, dry skin, or excessive sweating.
• Ocular – dry eye, blurred vision, or pupil abnormalities.

Focal neuropathies (mononeuropathies)

• Sudden, severe pain in the thigh, groin, or facial nerve (e.g., Bell’s palsy).
• Weakness in a specific muscle group (e.g., wrist drop).

Causes and Risk Factors

Diabetic neuropathy results from a complex interplay of metabolic, vascular, and inflammatory processes:

• Chronic hyperglycemia – high glucose damages nerve fibers directly and via advanced glycation end‑products (AGEs).
• Oxidative stress – excess free radicals injure axons and myelin.
• Ischemia – microvascular disease reduces blood flow to nerves.
• Inflammation – cytokines such as TNF‑α promote nerve degeneration.
• Genetic predisposition – certain gene variants (e.g., ACE, APOE) modestly increase susceptibility.

Key Risk Factors

• Long duration of diabetes (especially > 10 years).
• Poor glycemic control – HbA1c > 8 % markedly raises risk.
• Smoking – aggravates microvascular damage.
• Hypertension and dyslipidemia – potentiate vascular insufficiency.
• Obesity – contributes to insulin resistance and inflammation.
• Kidney disease (diabetic nephropathy) – associated with higher neuropathy prevalence.
• Alcohol misuse – synergistic neurotoxic effect.

Diagnosis

Diagnosing diabetic neuropathy is primarily clinical, supported by objective tests to assess severity and exclude other causes.

Clinical Evaluation

• Detailed medical history (duration of diabetes, symptom onset, glycemic trends).
• Physical examination focusing on sensation (monofilament, tuning fork), reflexes, muscle strength, and autonomic signs.

Common Tests

• 10‑g monofilament test – assesses protective sensation in the feet; inability to feel the filament predicts ulcer risk.
• Vibration perception threshold – using a 128‑Hz tuning fork or a biothesiometer.
• Electrophysiological studies (nerve conduction studies, electromyography) – detect large‑fiber dysfunction and help differentiate demyelinating vs. axonal patterns.
• Quantitative sensory testing (QST) – measures thresholds for temperature and pain.
• Autonomic testing – heart‑rate variability, Valsalva maneuver, and sweat‑spot test for sudomotor function.
• Laboratory work‑up to rule out other causes: vitamin B12, thyroid function, serum protein electrophoresis, HIV, and syphilis serology.

Treatment Options

Management is multi‑faceted: control the underlying diabetes, relieve pain, treat specific complications, and improve quality of life.

Glycemic Control

Intensive glucose management reduces the progression of neuropathy. The DCCT and UKPDS trials demonstrated a 35–50 % reduction in neuropathy incidence with tighter HbA1c targets (< 7 %).

Pharmacologic Pain Relief

Drug Class	Examples	Typical Dose	Key Side Effects
Antidepressants (SNRIs)	Duloxetine 60‑120 mg daily, Venlafaxine 75‑225 mg	Nausea, dry mouth, hypertension
Antidepressants (TCAs)	Amitriptyline 25‑150 mg, Nortriptyline 25‑100 mg	Sedation, anticholinergic effects, cardiac conduction delay
Anticonvulsants	Pregabalin 150‑600 mg/day, Gabapentin 900‑3600 mg/day	Dizziness, edema, weight gain
Topical agents	Capsaicin 0.075% cream, 8% patch (Qutenza)	Local burning, erythema
Opioids (reserved)	Tramadol, low‑dose morphine	Constipation, dependence; use only if other options fail.

Procedure‑Based Therapies

• Spinal cord stimulation – for refractory, chronic leg pain.
• Transcutaneous electrical nerve stimulation (TENS) – modest benefit in some patients.
• Sympathetic nerve blocks – occasionally used for severe autonomic pain.

Management of Autonomic Symptoms

• Orthostatic hypotension: increase fluid/salt intake, compression stockings, fludrocortisone.
• Gastroparesis: prokinetic agents (metoclopramide, erythromycin), dietary modifications.
• Erectile dysfunction: phosphodiesterase‑5 inhibitors (sildenafil) after cardiac clearance.

Lifestyle Interventions

• Exercise – 150 min/week of moderate aerobic activity improves blood flow and insulin sensitivity.
• Weight management – goal BMI < 30 kg/m².
• Smoking cessation – reduces microvascular injury.
• Foot care education – daily inspection, proper footwear, prompt treatment of lesions.

Living with Diabetic Neuropathy

Practical daily strategies help maintain function and prevent complications:

• Daily foot exam – use a mirror or ask a partner; look for cuts, redness, or calluses.
• Proper footwear – cushioned, well‑fitted shoes; consider custom orthotics if deformities exist.
• Temperature safety – use lukewarm water for bathing; avoid direct heat sources (heating pads) that can cause burns.
• Blood glucose monitoring – keep logbook; aim for target ranges set by your provider.
• Medication adherence – set reminders; discuss side‑effects promptly.
• Physical therapy – balance training and stretching to reduce fall risk.
• Psychological support – chronic pain can lead to depression; consider counseling or support groups.

Prevention

Since DN is largely preventable, focus on the modifiable factors:

1. Maintain optimal glycemic control – target HbA1c per ADA recommendations (generally < 7 % for most adults).
2. Control blood pressure and lipids – ACE inhibitors or ARBs for BP; statins for LDL‑C.
3. Adopt a balanced diet – high in fiber, low in refined carbs; Mediterranean‑style patterns are beneficial.
4. Regular physical activity – improves insulin sensitivity and peripheral circulation.
5. Avoid tobacco and limit alcohol – both accelerate nerve damage.
6. Routine screening – annual foot exam and neuropathy assessment for all diabetics.

Complications

If left untreated or poorly managed, diabetic neuropathy can lead to serious outcomes:

• Foot ulcers – loss of sensation allows minor trauma to progress unnoticed.
• Infections – ulcer‑related infections can lead to osteomyelitis.
• Amputations – up to 15 % of diabetics with neuropathy will undergo lower‑extremity amputation in their lifetime (CDC, 2023).
• Falls and fractures – due to balance impairment and proprioceptive loss.
• Cardiovascular events – autonomic neuropathy is linked with silent myocardial ischemia and increased mortality.
• Gastrointestinal complications – gastroparesis can cause malnutrition and erratic glucose control.
• Sexual dysfunction – reduced quality of life.

When to Seek Emergency Care

References

• American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Diabetic Neuropathy Fact Sheet. 2023.
• Mayo Clinic. Diabetic neuropathy: Symptoms & treatment. Updated 2024.
• Centers for Disease Control and Prevention. Diabetes and Foot Complications. 2023.
• Cleveland Clinic. Management of Neuropathic Pain in Diabetes. 2024.
• World Health Organization. Global report on diabetes. 2022.

```